Active Pharmaceutical Ingredients (API)-Europe Market Status and Trend Report 2013-2023
Report Summary
Active Pharmaceutical Ingredients (API)-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Active Pharmaceutical Ingredients (API) industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Active Pharmaceutical Ingredients (API) 2013-2017, and development forecast 2018-2023
Main market players of Active Pharmaceutical Ingredients (API) in Europe, with company and product introduction, position in the Active Pharmaceutical Ingredients (API) market
Market status and development trend of Active Pharmaceutical Ingredients (API) by types and applications
Cost and profit status of Active Pharmaceutical Ingredients (API), and marketing status
Market growth drivers and challenges
The report segments the Europe Active Pharmaceutical Ingredients (API) market as:
Europe Active Pharmaceutical Ingredients (API) Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Active Pharmaceutical Ingredients (API) Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Vitamin
Antibiotics
Antipyretic & Analgesic
Hormone
Amino Acid
Nervus Centralis
Others
Europe Active Pharmaceutical Ingredients (API) Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Others
Europe Active Pharmaceutical Ingredients (API) Market: Players Segment Analysis (Company and Product introduction, Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin):
Teva Active Pharmaceutical Industries Limited
DSM
Novartis
Roche
Johnson & Johnson
Dr. Reddy's
Pfizer
Bayer
BASF
Cambrex
Sun Pharmaceutical Industries
Lonza group
Boehringer Ingelheim GmbH
Aurobindo pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Active Pharmaceutical Ingredients (API)-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Active Pharmaceutical Ingredients (API) industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Active Pharmaceutical Ingredients (API) 2013-2017, and development forecast 2018-2023
Main market players of Active Pharmaceutical Ingredients (API) in Europe, with company and product introduction, position in the Active Pharmaceutical Ingredients (API) market
Market status and development trend of Active Pharmaceutical Ingredients (API) by types and applications
Cost and profit status of Active Pharmaceutical Ingredients (API), and marketing status
Market growth drivers and challenges
The report segments the Europe Active Pharmaceutical Ingredients (API) market as:
Europe Active Pharmaceutical Ingredients (API) Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Active Pharmaceutical Ingredients (API) Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Vitamin
Antibiotics
Antipyretic & Analgesic
Hormone
Amino Acid
Nervus Centralis
Others
Europe Active Pharmaceutical Ingredients (API) Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Others
Europe Active Pharmaceutical Ingredients (API) Market: Players Segment Analysis (Company and Product introduction, Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin):
Teva Active Pharmaceutical Industries Limited
DSM
Novartis
Roche
Johnson & Johnson
Dr. Reddy's
Pfizer
Bayer
BASF
Cambrex
Sun Pharmaceutical Industries
Lonza group
Boehringer Ingelheim GmbH
Aurobindo pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)
1.1 Definition of Active Pharmaceutical Ingredients (API) in This Report
1.2 Commercial Types of Active Pharmaceutical Ingredients (API)
1.2.1 Vitamin
1.2.2 Antibiotics
1.2.3 Antipyretic & Analgesic
1.2.4 Hormone
1.2.5 Amino Acid
1.2.6 Nervus Centralis
1.2.7 Others
1.3 Downstream Application of Active Pharmaceutical Ingredients (API)
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Development History of Active Pharmaceutical Ingredients (API)
1.5 Market Status and Trend of Active Pharmaceutical Ingredients (API) 2013-2023
1.5.1 EMEA Active Pharmaceutical Ingredients (API) Market Status and Trend 2013-2023
1.5.2 Regional Active Pharmaceutical Ingredients (API) Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Active Pharmaceutical Ingredients (API) in EMEA 2013-2017
2.2 Consumption Market of Active Pharmaceutical Ingredients (API) in EMEA by Regions
2.2.1 Consumption Volume of Active Pharmaceutical Ingredients (API) in EMEA by Regions
2.2.2 Revenue of Active Pharmaceutical Ingredients (API) in EMEA by Regions
2.3 Market Analysis of Active Pharmaceutical Ingredients (API) in EMEA by Regions
2.3.1 Market Analysis of Active Pharmaceutical Ingredients (API) in Europe 2013-2017
2.3.2 Market Analysis of Active Pharmaceutical Ingredients (API) in Middle East 2013-2017
2.3.3 Market Analysis of Active Pharmaceutical Ingredients (API) in Africa 2013-2017
2.4 Market Development Forecast of Active Pharmaceutical Ingredients (API) in EMEA 2018-2023
2.4.1 Market Development Forecast of Active Pharmaceutical Ingredients (API) in EMEA 2018-2023
2.4.2 Market Development Forecast of Active Pharmaceutical Ingredients (API) by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Active Pharmaceutical Ingredients (API) in EMEA by Types
3.1.2 Revenue of Active Pharmaceutical Ingredients (API) in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Active Pharmaceutical Ingredients (API) in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Active Pharmaceutical Ingredients (API) in EMEA by Downstream Industry
4.2 Demand Volume of Active Pharmaceutical Ingredients (API) by Downstream Industry in Major Countries
4.2.1 Demand Volume of Active Pharmaceutical Ingredients (API) by Downstream Industry in Europe
4.2.2 Demand Volume of Active Pharmaceutical Ingredients (API) by Downstream Industry in Middle East
4.2.3 Demand Volume of Active Pharmaceutical Ingredients (API) by Downstream Industry in Africa
4.3 Market Forecast of Active Pharmaceutical Ingredients (API) in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)
5.1 EMEA Economy Situation and Trend Overview
5.2 Active Pharmaceutical Ingredients (API) Downstream Industry Situation and Trend Overview
CHAPTER 6 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Active Pharmaceutical Ingredients (API) in EMEA by Major Players
6.2 Revenue of Active Pharmaceutical Ingredients (API) in EMEA by Major Players
6.3 Basic Information of Active Pharmaceutical Ingredients (API) by Major Players
6.3.1 Headquarters Location and Established Time of Active Pharmaceutical Ingredients (API) Major Players
6.3.2 Employees and Revenue Level of Active Pharmaceutical Ingredients (API) Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Teva Active Pharmaceutical Industries Limited
7.1.1 Company profile
7.1.2 Representative Active Pharmaceutical Ingredients (API) Product
7.1.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Teva Active Pharmaceutical Industries Limited
7.2 DSM
7.2.1 Company profile
7.2.2 Representative Active Pharmaceutical Ingredients (API) Product
7.2.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of DSM
7.3 Novartis
7.3.1 Company profile
7.3.2 Representative Active Pharmaceutical Ingredients (API) Product
7.3.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Novartis
7.4 Roche
7.4.1 Company profile
7.4.2 Representative Active Pharmaceutical Ingredients (API) Product
7.4.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Roche
7.5 Johnson & Johnson
7.5.1 Company profile
7.5.2 Representative Active Pharmaceutical Ingredients (API) Product
7.5.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.6 Dr. Reddy's
7.6.1 Company profile
7.6.2 Representative Active Pharmaceutical Ingredients (API) Product
7.6.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Dr. Reddy's
7.7 Pfizer
7.7.1 Company profile
7.7.2 Representative Active Pharmaceutical Ingredients (API) Product
7.7.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Pfizer
7.8 Bayer
7.8.1 Company profile
7.8.2 Representative Active Pharmaceutical Ingredients (API) Product
7.8.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Bayer
7.9 BASF
7.9.1 Company profile
7.9.2 Representative Active Pharmaceutical Ingredients (API) Product
7.9.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of BASF
7.10 Cambrex
7.10.1 Company profile
7.10.2 Representative Active Pharmaceutical Ingredients (API) Product
7.10.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Cambrex
7.11 Sun Pharmaceutical Industries
7.11.1 Company profile
7.11.2 Representative Active Pharmaceutical Ingredients (API) Product
7.11.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
7.12 Lonza group
7.12.1 Company profile
7.12.2 Representative Active Pharmaceutical Ingredients (API) Product
7.12.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Lonza group
7.13 Boehringer Ingelheim GmbH
7.13.1 Company profile
7.13.2 Representative Active Pharmaceutical Ingredients (API) Product
7.13.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH
7.14 Aurobindo pharma
7.14.1 Company profile
7.14.2 Representative Active Pharmaceutical Ingredients (API) Product
7.14.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Aurobindo pharma
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)
8.1 Industry Chain of Active Pharmaceutical Ingredients (API)
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)
9.1 Cost Structure Analysis of Active Pharmaceutical Ingredients (API)
9.2 Raw Materials Cost Analysis of Active Pharmaceutical Ingredients (API)
9.3 Labor Cost Analysis of Active Pharmaceutical Ingredients (API)
9.4 Manufacturing Expenses Analysis of Active Pharmaceutical Ingredients (API)
CHAPTER 10 MARKETING STATUS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Active Pharmaceutical Ingredients (API) in This Report
1.2 Commercial Types of Active Pharmaceutical Ingredients (API)
1.2.1 Vitamin
1.2.2 Antibiotics
1.2.3 Antipyretic & Analgesic
1.2.4 Hormone
1.2.5 Amino Acid
1.2.6 Nervus Centralis
1.2.7 Others
1.3 Downstream Application of Active Pharmaceutical Ingredients (API)
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Development History of Active Pharmaceutical Ingredients (API)
1.5 Market Status and Trend of Active Pharmaceutical Ingredients (API) 2013-2023
1.5.1 EMEA Active Pharmaceutical Ingredients (API) Market Status and Trend 2013-2023
1.5.2 Regional Active Pharmaceutical Ingredients (API) Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Active Pharmaceutical Ingredients (API) in EMEA 2013-2017
2.2 Consumption Market of Active Pharmaceutical Ingredients (API) in EMEA by Regions
2.2.1 Consumption Volume of Active Pharmaceutical Ingredients (API) in EMEA by Regions
2.2.2 Revenue of Active Pharmaceutical Ingredients (API) in EMEA by Regions
2.3 Market Analysis of Active Pharmaceutical Ingredients (API) in EMEA by Regions
2.3.1 Market Analysis of Active Pharmaceutical Ingredients (API) in Europe 2013-2017
2.3.2 Market Analysis of Active Pharmaceutical Ingredients (API) in Middle East 2013-2017
2.3.3 Market Analysis of Active Pharmaceutical Ingredients (API) in Africa 2013-2017
2.4 Market Development Forecast of Active Pharmaceutical Ingredients (API) in EMEA 2018-2023
2.4.1 Market Development Forecast of Active Pharmaceutical Ingredients (API) in EMEA 2018-2023
2.4.2 Market Development Forecast of Active Pharmaceutical Ingredients (API) by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Active Pharmaceutical Ingredients (API) in EMEA by Types
3.1.2 Revenue of Active Pharmaceutical Ingredients (API) in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Active Pharmaceutical Ingredients (API) in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Active Pharmaceutical Ingredients (API) in EMEA by Downstream Industry
4.2 Demand Volume of Active Pharmaceutical Ingredients (API) by Downstream Industry in Major Countries
4.2.1 Demand Volume of Active Pharmaceutical Ingredients (API) by Downstream Industry in Europe
4.2.2 Demand Volume of Active Pharmaceutical Ingredients (API) by Downstream Industry in Middle East
4.2.3 Demand Volume of Active Pharmaceutical Ingredients (API) by Downstream Industry in Africa
4.3 Market Forecast of Active Pharmaceutical Ingredients (API) in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)
5.1 EMEA Economy Situation and Trend Overview
5.2 Active Pharmaceutical Ingredients (API) Downstream Industry Situation and Trend Overview
CHAPTER 6 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Active Pharmaceutical Ingredients (API) in EMEA by Major Players
6.2 Revenue of Active Pharmaceutical Ingredients (API) in EMEA by Major Players
6.3 Basic Information of Active Pharmaceutical Ingredients (API) by Major Players
6.3.1 Headquarters Location and Established Time of Active Pharmaceutical Ingredients (API) Major Players
6.3.2 Employees and Revenue Level of Active Pharmaceutical Ingredients (API) Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Teva Active Pharmaceutical Industries Limited
7.1.1 Company profile
7.1.2 Representative Active Pharmaceutical Ingredients (API) Product
7.1.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Teva Active Pharmaceutical Industries Limited
7.2 DSM
7.2.1 Company profile
7.2.2 Representative Active Pharmaceutical Ingredients (API) Product
7.2.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of DSM
7.3 Novartis
7.3.1 Company profile
7.3.2 Representative Active Pharmaceutical Ingredients (API) Product
7.3.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Novartis
7.4 Roche
7.4.1 Company profile
7.4.2 Representative Active Pharmaceutical Ingredients (API) Product
7.4.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Roche
7.5 Johnson & Johnson
7.5.1 Company profile
7.5.2 Representative Active Pharmaceutical Ingredients (API) Product
7.5.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.6 Dr. Reddy's
7.6.1 Company profile
7.6.2 Representative Active Pharmaceutical Ingredients (API) Product
7.6.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Dr. Reddy's
7.7 Pfizer
7.7.1 Company profile
7.7.2 Representative Active Pharmaceutical Ingredients (API) Product
7.7.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Pfizer
7.8 Bayer
7.8.1 Company profile
7.8.2 Representative Active Pharmaceutical Ingredients (API) Product
7.8.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Bayer
7.9 BASF
7.9.1 Company profile
7.9.2 Representative Active Pharmaceutical Ingredients (API) Product
7.9.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of BASF
7.10 Cambrex
7.10.1 Company profile
7.10.2 Representative Active Pharmaceutical Ingredients (API) Product
7.10.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Cambrex
7.11 Sun Pharmaceutical Industries
7.11.1 Company profile
7.11.2 Representative Active Pharmaceutical Ingredients (API) Product
7.11.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
7.12 Lonza group
7.12.1 Company profile
7.12.2 Representative Active Pharmaceutical Ingredients (API) Product
7.12.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Lonza group
7.13 Boehringer Ingelheim GmbH
7.13.1 Company profile
7.13.2 Representative Active Pharmaceutical Ingredients (API) Product
7.13.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH
7.14 Aurobindo pharma
7.14.1 Company profile
7.14.2 Representative Active Pharmaceutical Ingredients (API) Product
7.14.3 Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of Aurobindo pharma
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)
8.1 Industry Chain of Active Pharmaceutical Ingredients (API)
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)
9.1 Cost Structure Analysis of Active Pharmaceutical Ingredients (API)
9.2 Raw Materials Cost Analysis of Active Pharmaceutical Ingredients (API)
9.3 Labor Cost Analysis of Active Pharmaceutical Ingredients (API)
9.4 Manufacturing Expenses Analysis of Active Pharmaceutical Ingredients (API)
CHAPTER 10 MARKETING STATUS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
